Each month, we compile and present a comprehensive up-to-date list of recently started clinical trials to keep you informed of the latest advancements and research in the medical field. To be the first to know about new clinical trials Register Now for free

The below are the clinical trials posted for the first time in June 2024.

Phase 4:

  1. Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma
  2. PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
  3. A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
  4. Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
  5. Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma
  6. Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis

Phase 3:

  1. Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma
  2. P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
  3. Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery
  4. Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
  5. Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
  6. Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy
  7. A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
  8. Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
  9. Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Ttransanal Endoscopic Microsurgery in T1 N0, M0 Rectal Cancer (TAUTEM-T1 Study)
  10. EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study
  11. A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)
  12. Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases
  13. A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients
  14. Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
  15. A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC
  16. A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
  17. A Study to Learn More About How Well BAY 2927088 Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Human Epidermal Growth Factor Receptor 2 (HER2)
  18. Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
  19. Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
  20. Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
  21. Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients
  22. SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC
  23. BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer
  24. TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma
  25. High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma
  26. A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
  27. A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma
  28. Confirmatory Study of Topical HyBryteβ„Ά vs. Placebo for the Treatment of CTCL
  29. A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis
  30. Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
  31. A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (RemeMG)
  32. Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

Phase 2-3:

  1. Interventional Software for Multi-immunotherapy of Solid Tumors
  2. QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
  3. Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis
  4. Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab
  5. Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
  6. Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy
  7. Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction
  8. Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial
  9. Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
  10. Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer
  11. Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme
  12. Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor
  13. Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases
  14. Avutometinib and Defactinib in Diffuse Gastric Cancer
  15. A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
  16. Synergistic Effects of PD-1 Antibody and Chemotherapy Followed by Surgery in Limited-metastatic G/GEJ Adenocarcinoma
  17. NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
  18. Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer
  19. A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
  20. Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
  21. Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel, Serabelisib With Paclitaxel, and Paclitaxel Alone in Patients With Advanced/Recurrent Endometrial Cancer
  22. Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy
  23. Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE)
  24. PET/MRI to Stage Prostate Cancer Patients
  25. Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
  26. Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer
  27. An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer
  28. Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
  29. 177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer
  30. Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
  31. The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
  32. Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer
  33. Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer
  34. A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause
  35. Exploratory Clinical Trial to Safety and Efficacy of SAT-003 in Cancer Cachexia Patients Discontinued Chemotherapy Who Had Diagnosed With Solid Cancer
  36. Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
  37. A Phase II Trial of Adebrelimab in Combination With NALIRIFOX in LAPC
  38. To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer
  39. Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
  40. Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
  41. Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction
  42. Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.
  43. Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT
  44. Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer
  45. Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer
  46. Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer
  47. Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
  48. Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal Metastasis
  49. TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients
  50. Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer
  51. A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast Cancer
  52. Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies
  53. Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases
  54. INVERT - Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy
  55. A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
  56. Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.
  57. The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer
  58. Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC
  59. T-DM1 Combined With CDK4/6 Inhibitor Ribociclib
  60. A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy
  61. Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial
  62. Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC
  63. BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
  64. Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance Using Peripheral Blood Clonotypic Mass Spectrometry
  65. Adebrelimab Plus Chemo and Recaticimab Perioperative Treatment for Resectable NSCLC
  66. Efficacy and Safety of Anti-PD-1, Thymosin, and SOX in Neoadjuvant Treatment of cStage III Gastric/GEJ Adenocarcinoma
  67. A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer
  68. Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs
  69. Proton Therapy for Locally Advanced Cervical Cancer
  70. Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement
  71. NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
  72. Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric Cancer
  73. Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer
  74. Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer
  75. A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC
  76. Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
  77. Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's of Choice Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer (VIRO-25)
  78. Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer
  79. Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC
  80. Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases
  81. Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
  82. Effect of N-acetyl Cysteine and Zinc in Management of Head and Neck Cancer Radiotherapy Induced Oral Mucositis
  83. LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  84. Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery
  85. CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
  86. Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)
  87. Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)
  88. A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment
  89. NALIRIFOX as Induction Therapy in LAPC
  90. Adebrelimab + Apatinib in SCLC Maintenance Therapy
  91. HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study
  92. A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
  93. A Prospective, Randomised Controlled, Phase II Clinical Study of Tirilizumab in Combination With Albumin-bound Paclitaxel With Cisplatin for Neoadjuvant and Adjuvant Treatment of Locally Advanced Resectable Oral Squamous Cell Carcinoma
  94. A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma
  95. AGNOSTIC THERAPY IN A PHASE II SINGLE-ARM STUDY IN FIRST-LINE TREATMENT OF DURVALUMAB IN ASSOCIATION WITH CARBOPLATIN OR CISPLATIN AND ETOPOSIDE IN PATIENTS AFFECTED BY EXTENSIVE STAGE - EXTRAPULMONARY SMALL CELL CARCINOMA
  96. AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients
  97. A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
  98. Short-course Radiotherapy Combined With Sintilimab for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
  99. A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
  100. SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment
  101. Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC
  102. GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma
  103. HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma
  104. Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC
  105. Clinical Study of Mitoxantrone Hydrochloride Liposome Combined With PD-1 Blockade in Recurrent or Metastatic NPC
  106. Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
  107. Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study
  108. Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas
  109. The Efficacy of Gemcitabine and Nab-palitaxe Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Patients With Locally Advanced Pancreatic Ductal Adenocarcinoma
  110. The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy
  111. CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML
  112. A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
  113. Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML
  114. A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
  115. Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma
  116. CMOPΒ±R in the Treatment of Untreated Non-Hodgkin's Lymphoma
  117. A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma
  118. A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
  119. Epcoritamab-CAR T Cells for Large B-cell Lymphomas
  120. CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma
  121. Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma
  122. A Phase ll Trial of the Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma
  123. Reduced Intensity Conditioning With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory Peripheral T-cell Lymphoma.
  124. Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma
  125. Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
  126. Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.
  127. TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
  128. Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

Phase 1-2:

  1. 61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)
  2. A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
  3. A Clinical Study of YL205 in Patients With Advanced Solid Tumors
  4. A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or Metastatic Solid Tumors
  5. A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
  6. A Study of GQ1010 in Subjects With Advanced Solid Tumors
  7. A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1)
  8. A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors
  9. Difluoromethylornithine (DFMO) and AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas
  10. Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
  11. Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
  12. Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
  13. Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
  14. A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
  15. Study to Assess Adverse Events and How Intravenously (IV) Infused ABBV-400 Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer
  16. Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
  17. Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma
  18. ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
  19. Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors
  20. Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer
  21. Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer
  22. Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
  23. A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy
  24. A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer
  25. A Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer
  26. Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer
  27. Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)
  28. Radiotherapy to All Residual Lesions After Chemoimmunotherapy
  29. D2C7-IT + 2141-V11 Combination Post-resection in rGBM
  30. Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma
  31. Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma
  32. Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy
  33. Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma
  34. Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC
  35. To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization
  36. A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)
  37. Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET
  38. A Phase 1/2 Trial of ADI-270 in ccRCC
  39. A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma
  40. Selinexor、Venetoclax and Azactidine in the Treatment of ND AML Patients Who Are Not Eligible for Intense Chemotherapy
  41. Puesta Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
  42. A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma
  43. TCR Reserved and Power3 Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL
  44. VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS

Phase 1:

  1. A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
  2. Study of AXT-1003 in Subjects With Advanced Malignant Tumors.
  3. A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001)
  4. [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
  5. Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies
  6. A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
  7. A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors
  8. An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
  9. A Study of BL-B16D1 in Patients With Locally Advanced or Metastatic Solid Tumors
  10. NW-301 TCR-T in Patients With Advanced Solid Tumor
  11. NW-301 TCR-T in Patients With Advanced Solid Tumor
  12. NW-301 TCR-T in Patients With Advanced Solid Tumor
  13. Anti-cancer DC Cell Vaccination to Treat Solid Tumors
  14. TGRX-1942 Chinese Phase I for Advanced Solid Tumor and/or Relapsed/Refractory Hematologic Malignancies
  15. Study of SGR-3515 In Participants With Advanced Solid Tumors.
  16. First In Human Study of CX-801 in Advanced Solid Tumors
  17. Study of DNP002 in Patients With Solid Tumors
  18. A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.
  19. A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors
  20. Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
  21. Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
  22. A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years
  23. To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects
  24. A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
  25. A Study of SGN-MesoC2 in Advanced Solid Tumors
  26. A Study of PHN-010 in Patients With Advanced Solid Tumors
  27. An Engineered SirpΞ± Fused to Anti-Pd-L1 And Tgf-Ξ² Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
  28. A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
  29. IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations
  30. NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
  31. A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
  32. Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
  33. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
  34. A Study of DM001 in Patients With Advanced Solid Tumors
  35. Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
  36. A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
  37. Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
  38. Clinical Study of 68Ga-LNC1007 Injection PET/CT
  39. Clinical Study of 18F-LNC1007 Injection PET/CT
  40. Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
  41. A Phase β… b Study on Autologous GC101 TIL Injection for the Treatment of NSCLC
  42. Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
  43. Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
  44. T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
  45. Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
  46. MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
  47. Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
  48. A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)
  49. Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
  50. A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of JCXH-211 (SElf-Replicating RNA IL-12) Intratumoral Injection in Patients With Recurrent or Progressive High-Grade Glioma
  51. Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG)
  52. Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 and ASTX727 With Venetoclax to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
  53. A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
  54. Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma
  55. Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
  56. A Clinical Study of SHR-9539 in Patients With Multiple Myeloma
  57. Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Hard-to-Treat Multiple Myeloma
  58. A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias
  59. A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias
  60. Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
  61. A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
  62. ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML
  63. L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma
  64. Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma
  65. Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia
  66. A Study to Evaluate the MNV-201 in Patients With Low Risk MDS

Early Phase 1:

  1. 68Ga-JH04 PET/CT in Patients With Various Types of Cancer
  2. 68Ga-DOTA-NI-FAPI04 PET/CT in Patients With Various Types of Cancer
  3. [68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors
  4. A Study on TIL for the Treatment of Advanced Solid Tumors
  5. Colorectal Cancer Legal and Administrative Burden Support: A Pilot Clinical Trial
  6. Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer
  7. Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid Tumors
  8. Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
  9. Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
  10. FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
  11. Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma
  12. Universal CAR-T Cells in Patients With Refractory Autoimmune Diseases of the Nervous System.

Phase Not Applicable:

  1. Evaluate the Efficacy and Safety of Interferon-Ξ± Combined With ATO in the Treatment of Arsenic-resistant APL
  2. CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT
  3. Interpretability of the QuantraΒ® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L.
  4. TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors
  5. BMT-CARE: Psychosocial Intervention for Transplant Caregivers
  6. Endometrial Cell Collection With the PadKit
  7. PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications
  8. Nudge to Gynecologic Oncology
  9. Feasibility and Added Value of the TRACMOTION Device for ESD
  10. Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
  11. A Novel Adaptive Anastomotic Technique for Left-sided Colonic and Rectal Resection
  12. Mental Health App for Cancer Survivors Study
  13. ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
  14. Effectiveness of Artificial Intelligence - Assisted Colonoscopy in Colorectal Neoplasms
  15. HEME Home Transfusion Program
  16. Development and Application Study of ePRO Software for Managing Cancer Patients Throughout the Treatment Period
  17. Ambulatory Surgery After Hepatectomy: Monitoring by Domomedicine Connected Tools and a Dedicated Nurse.
  18. Tumour Localisation With Magnetic Clip Before Neoadjuvant Chemotherapy.
  19. Impact of Virtual Reality on the Quality of Life of Oncology Patients
  20. Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatment of Mucositis Induced by Radiotherapy, During the Treatment of Head and Neck Cancers
  21. Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients
  22. The Effect of Active Nutritional Support On Quality Of Life In Patients With Head And Neck Cancer Receiving Radiotherapy
  23. Local Liver Treatment for Multi-organ Colorectal Cancer Metastases
  24. Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
  25. Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
  26. Evaluation of the Use of Minced Skin Grafts for Promoting Donor Site Wound Healing After Split-Thickness Skin Grafting
  27. Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours
  28. Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage
  29. Investigation of the Effect of Acceptance and Commitment Therapy-Based Intervention in Oncology Patients
  30. Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
  31. Testing Gene PilotLX With Latinx Cancer Patients
  32. Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System
  33. Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate Cancer
  34. Evaluation of a Simple-Prep Controlled Embolic
  35. Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors
  36. Heart Analysis in GATED-PET in Patients Having a Gallium-68-DOTATOC PET/CT Exam for Oncology Indication
  37. Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care
  38. Supportive Clinic for Patients Living With Advanced and Metastatic Cancers
  39. Metacognitive Intervention in Youth With Oncological Disease - the Mio Study
  40. Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.
  41. Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years
  42. Assessment of DW-MRI Measures : Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy Volunteers
  43. A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework
  44. OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
  45. Pneumonitis in Older Lung Cancer Patients After Radiotherapy
  46. Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction
  47. Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
  48. Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer
  49. Vasomotor Symptom Alleviation Through Acupuncture in Patients With Prostate Cancer
  50. Evaluation of a Patient 'Nudge' on Engagement in Lung Cancer Screening
  51. Cancer Of the BReast Asanas (COBRA) Study
  52. Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer Patients
  53. Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
  54. Efficacy and Safety of Multimode Thermal Therapy in the Treatment of Early Peripheral Lung Cancer
  55. Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection
  56. The Impact of Respiratory Training of DIBH Radiotherapy for Breast Cancer
  57. Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)
  58. Aurora: A Human-centered Program for Breast Cancer Patients in Chile, Easing Neoadjuvant Chemotherapy's Effects
  59. Effects Of Concentric Cycling Training Protocol During (Neo)Adjuvant Chemotherapy in Breast Cancer Patients: PROTECT-07 Study
  60. A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer
  61. Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors
  62. Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined With Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer
  63. Evaluation of the Effectiveness of the Combined Psychological Resilience and Self-efficacy Intervention for Improving Resilience and Self-efficacy and Reducing Anxiety and Depression of Oesophageal Cancer Surgery Patients
  64. Training for Men Undergoing Androgen Deprivation Therapy.
  65. SpaceIT Hydrogel System for Perirectal Spacing
  66. Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
  67. Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian Masses
  68. Camera Capsule Endoscopy in the Routine Diagnostic Pathway for Colorectal Diseases
  69. A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers
  70. Mechanisms for Laser-Induced Rejuvenation
  71. OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
  72. The Effect of Hemodilution on Intraoperative Allogeneic Transfusion (HEAL)
  73. Getting To Implementation: Improving Cancer Screening for Veterans
  74. Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics
  75. Correlation of Portal and Peripheral Venous ctDNA in Pancreatic Adenocarcinoma
  76. Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients
  77. Dermatitis During Adjuvant Irradiation for BREAst Cancer:
  78. Clinical Effectiveness of CEM in Diagnosis of Additional Findings at Preoperative Breast Magnetic Resonance Imaging
  79. Research on Building and Application of Internet-based Home Pre-rehabilitation Model for Lung Surgery Patients.
  80. To Live Better After Breast Cancer Treatment
  81. Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid
  82. Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer
  83. Patient Priorities for Survivorship Care in Older Breast Cancer Survivors
  84. Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the Tongue
  85. The Effect of Meditation on Resilience and Spiritual Well-Being Levels
  86. Regorafenib and Sintilimab in Combination With Electroacupuncture in MSS CRC
  87. Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents
  88. Dynamic 68Ga-PSMA and 18F-FDG PET/CT Analysis Prior to 177Lu-PSMA
  89. Shortened High-dose Palliative Radiotherapy for Lung Cancer
  90. Feasibility of CALM in Patients With Ovarian Cancer
  91. The Effect of Stress Ball Application on Stress, Anxiety and Comfort During Chemotherapy in Women With Breast Cancer
  92. Comprehensive Health Assessment for My Plan: Initial Implementation Study (CHAMP Implementation Study)
  93. Trial of Artificial Intelligence for Chest Radiography
  94. Pocket Colposcopy Using CARE Algorithm
  95. Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Small Cell Lung Cancer
  96. Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer
  97. Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study
  98. LiveWell: Adapted DBT Skills Training for Metastatic Lung Cancer
  99. Acupressure on Xerostomia in Head and Neck Cancer Patients
  100. Efficacy of Almonertinib Combined With Upfront Stereotactic Ablative Body Radiotherapy to Residual Primary Lung Lesions in Advanced Non-small Cell Lung Cancer
  101. ERAS in Totally Laparoscopic Total Gastrectomy for Gastric Cancer
  102. Intra-SURGerY High-resolution Specimen PET/CT Imager for Margin Assessment in Early-stage Breast Cancer
  103. Patient-centered Dosage of Levothyroxine
  104. Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study
  105. The Effect of Hippotherapy on The Development of Life Satisfaction, Health Literacy and Healthism Attitude of Young Adults After Cancer Treatment
  106. Sexual Health and Rehabilitation Online (SHAREonline)
  107. Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC)
  108. SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer
  109. Study on Female Patients' Mammographic Texture Features
  110. Time to Return of Bowel Function Following Perioperative Probiotics in Colorectal Cancer Surgery
  111. Multiple Risk Factor Intervention Trial in Breast Cancer Survivors
  112. Safety and Efficacy Of Amber Peripheral Liquid Embolic System
  113. In Vivo Liquid Biopsy of Melanoma Melanoma (Cytophone)
  114. Management of Chronic Non-Cancer Pain With Non-Pharmacological Therapies
  115. The Effects of VC Versus PC Ventilation on Cerebral and Respiratory Parameters in Patients Undergoing Laparoscopic Gynecologic Surgery
  116. Safer Personalised Cancer Treatment Digital Follow-up
  117. OSCAR I STUDY - The Onco Seraph CTC Removal Study
  118. Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
  119. Efficacy of a Mixed Distancial Neuropsychological Rehabilitation Program in Patients With Grade 2 or 3 Diffuse Glioma
  120. Feasibility of a Youth-led NCD Risk Reduction Initiative in Selected Schools of Slums in Karachi, Pakistan: a Mixed-methods, pre-and Post-intervention Study
  121. Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy
  122. Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy
  123. Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study
  124. Effectiveness and Safety of ArcBlate Palliative Treatment for Patients With Painful Bone Metastases: A Pivotal Study
  125. EXercise Enhancement After RadioTherapy for Bone Metastases
  126. GDFT on the Postoperative Outcome in Head and Neck Cancer Surgery
  127. Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer
  128. The Effects of Parent-Child Activity Program on PA of Children With Cancer
  129. Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
  130. Cold Snare Piecemeal Resection vs Cold Snare Endoscopic Mucosal Resection
  131. IMPT Dose Escalation for NSCLC (HyDose)
  132. Efficacy of Fullerene in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .
  133. Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials
  134. Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection
  135. Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening
  136. Enhanced vs. Routine Follow-Up After Total Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial
  137. Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study
  138. Robotic Natural Orifice Specimen Extraction Surgery Compared to Robotic Assisted Surgery for Median Rectal Cancer
  139. Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions
  140. Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas
  141. FET-PET-Guided Management of Pseudoprogression in Glioblastoma
  142. Application of MET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme
  143. Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy
  144. Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer
  145. Music Therapy at TMH Infusion Center
  146. Evaluation of the Efficacy of Compression With Tight Surgical Gloves in Patients With Taxane-based Therapy
  147. Ga-68 FAPI PET Before Immunotherapy
  148. Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR）
  149. Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study
  150. Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
  151. Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib
  152. Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma
  153. Novel Digital Application for Patients With Acute Leukemia
  154. Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma
  155. LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma
  156. Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study
  157. Prospective Clinical Study of Obrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy
  158. Role of Left Stellate Ganglion Block in Offering Myocardial Protection in On-pump Mitral Valve Replacement? A Histopathological and Clinical Assessment
  159. Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL
  160. Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
  161. Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
  162. The Role of Adjuvant Albendazole After Pulmonary Hydatid Cyst Resection
  163. Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls


Note

The above Clinical Trial information has been retrieved from ClinicalTrials.gov